Skip to content

cCeLL CX100-2W2C488775

by VPIX Medical, Inc.

cCeLL CX100-2W2C488775 is a scanning laser optical microscope (FDA Class I; FDA product code IBK, Microscope, Fluorescence/U.V.) made by VPIX Medical, Inc., listed in FDA GUDID since 5 Dec 2023 (UDI-DI 08800112400192), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number08800112400192 UDI-DI Date5 Dec 2023ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Brand Name: cCeLL Device Name: cCeLL - Ex vivo Model Name:CX100-2W2C488775
MRI safety
MR Unsafe
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
cCeLL
Generic name
Scanning laser optical microscope
Model / reference
CX100-2W2C488775
Description
Brand Name: cCeLL Device Name: cCeLL - Ex vivo Model Name:CX100-2W2C488775
Primary DI / UDI-DI
08800112400192
FDA product code
IBK
GMDN term
Scanning laser optical microscope
Device class
Class I
Regulation number
864.3600
GUDID distribution status
In Commercial Distribution
MRI safety
MR Unsafe

Other devices from VPIX Medical, Inc.

  • cCeLL - In vivo

    Class II
  • cCeLL CN100-1W1C775

    Class II
  • cCeLL DR200

    Class II
  • cCeLL CN100-2W2C488775

    Class II

See all devices from VPIX Medical, Inc. →

Properties

  • Premarket exempt
  • Serial number
  • Manufacturing date
Other properties (12, all answered No)